Developer docs
API playgroundTry for free, no card

Search company profiles

Docuvera

Full company profile

uuid00087t6

Namestring
Docuvera
Legal namestring
Docuvera Software Corporation
Websiteurl
docuvera.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Docuvera, operating as Docuvera Software Corporation, is a private Seattle-based software company that provides an AI-powered structured content authoring platform purpose-built for regulated life sciences documentation. The company serves enterprise and mid-sized pharmaceutical organizations globally, with offices in Seattle (North America), Wellington and Palmerston North (APAC), and Gütersloh (Europe), and a stated customer footprint across the U.S., EU, APAC, and LATAM. Named reference customers include Eli Lilly and Boehringer Ingelheim.

The platform is built on a modular, component-based content architecture with metadata tagging, component-level version control, audit history, and a governance layer providing role-based access control, GxP-aligned workflow orchestration, and change propagation across linked documents. It is delivered as validated SaaS hosted on SOC 2 Type 2 and ISO 27001 certified infrastructure, with alignment to 21 CFR Part 11 and EU Annex 11. The product portfolio spans a core platform and seven specialized modules covering Global Labeling, Clinical, Chemistry Manufacturing & Controls, Medical Information, Pharmacovigilance & Safety, Quality & SOPs, and a Governance Layer, supplemented by an AI Co-writer that uses retrieval-augmented generation with human-in-the-loop controls. The platform integrates with LIMS, MES, safety and clinical systems, RIM, translation management systems, and standards including HL7 FHIR, CDISC, USDM, ISO IDMP, and TransCelerate DDF, and publishes outputs in eCTD, PDF, XML, SPL, ePI, Word, and HTML formats. Documented customer outcomes include up to 80% content reuse across labeling outputs, 65% component reuse at Eli Lilly in the first year, 30–50% reduction in change implementation cycle time, 30–40% reduction in review cycle times, and 60% fewer downstream publishing errors.

Docuvera monetizes via a recurring SaaS subscription model, sold through direct enterprise sales engagement, demo requests, and website contact forms. Pricing is not publicly disclosed and is negotiated on a quote basis. The company employs 51–100 people and is privately held with no disclosed parent company, venture capital funding, or ownership changes identified. Distribution is direct, with no disclosed reseller or marketplace channels, and go-to-market is reinforced by content marketing, industry conference participation, and thought-leadership assets aimed at regulatory, clinical, and labeling functions within pharmaceutical companies.

Short descriptiontext

Docuvera is a private Seattle-based SaaS company that provides an AI-powered, component-based structured content authoring platform for regulated life sciences documentation, serving enterprise and mid-sized pharmaceutical companies with modules covering labeling, clinical, CMC, medical information, pharmacovigilance, quality, and governance workflows.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersWellington, New Zealand
HQ citystring
Wellington
HQ countrystring
New Zealand
HQ regionstring
Oceania
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
structured content authoring, pharmaceutical documentation, regulatory content management, life sciences compliance software, pharma labeling platform
Industry1 code
PRIMARYHLACAOAA
Electronic Data Capture (EDC) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
NAICS code1 code
  • Software Publishers5132
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Pharmaceutical Regulatory Content Management Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1SaaS Subscription Platform
TypeSubscription Recurring
Description

Docuvera operates as a validated SaaS solution providing access to their structured content authoring platform on a subscription basis. The platform is hosted on SOC 2 Type 2 certified infrastructure, indicating a cloud-hosted delivery model with recurring subscription fees.

docuvera.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1Cormeo
Description

A sub-brand or platform mentioned on the company's About page, operating under Docuvera's umbrella.

docuvera.com
Core offering1 text field

Docuvera is an AI-powered structured content authoring SaaS platform purpose-built for regulated life sciences documentation. The platform replaces document-first workflows with modular, version-controlled content components that can be authored once and reused across teams, document types, and global markets, supporting use cases spanning global labeling, clinical, CMC, medical information, pharmacovigilance, and quality/SOP documentation. It is hosted on SOC 2 Type 2 certified infrastructure and certified to ISO 27001, with built-in support for 21 CFR Part 11 and Annex 11 compliance.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • Up to 80% content reuse across CCDS, SmPC, USPI, and ePI outputs
+7 more records
Product overview1 text field

Docuvera is a unified AI-powered structured content authoring platform purpose-built for regulated life sciences content, comprising a core platform with integrated modules for specific use cases. The platform architecture centers on the Docuvera Platform as the foundation, which enables modular, version-controlled content components that can be authored once and reused across multiple outputs. The solution portfolio includes specialized modules: Global Labeling for CCDS, SmPC, USPI, and ePI management; Clinical for trial documentation; Chemistry, Manufacturing & Controls (CMC) for Module 3 content; Medical Information for scientific response management; Pharmacovigilance & Safety for safety reporting; and Quality & SOPs for quality documentation. A Governance Layer provides enterprise-wide controls including component-level version control, RBAC, and change propagation. The AI Co-writer feature enhances the platform with generative AI capabilities for accelerated drafting and reuse recommendations. All modules share the same underlying platform, content repository, and governance framework, enabling true cross-functional reuse—content created in one module can be surfaced and reused in others.

Product and service8 records
1Docuvera Platform
CategoryCore Platform
Description

AI-powered structured content authoring platform purpose-built for regulated life sciences content. Replaces scattered files with modular, traceable, and compliant content components that can be created once and reused across teams, document types, and global markets. For pharmaceutical and life sciences regulatory, clinical, CMC, medical information, safety, and quality teams.

2Global Labeling
CategoryRegulatory Labeling Solution
Description

Structured content solution for global pharmaceutical labeling including CCDS, SmPC, USPI, and ePI, with support for local and global needs, variant control, and multiformat publishing. For global and local regulatory labeling teams in pharmaceutical companies.

3Clinical
CategoryClinical Documentation Solution
Description

Clinical trial documentation solution enabling standardization of protocols, CSRs, and investigator brochures to streamline workflows, reduce rework, and enable modular collaboration across clinical teams. For clinical operations, medical writing, and regulatory teams.

4Chemistry, Manufacturing, & Controls (CMC)
CategoryCMC Documentation Solution
Description

CMC documentation solution enabling modular authoring and content reuse for Module 3 and site-specific variations, with support for upstream data integration from LIMS, MES, and manufacturing systems. For CMC and regulatory teams managing Module 3 content, product specifications, and variation submissions.

5Medical Information
CategoryMedical Information Solution
Description

Medical information solution for managing modular scientific response content with traceability across formats, regions, and delivery channels including digital endpoints, AEM-powered websites, chatbots, and field medical tools. For medical information and medical affairs teams.

6Pharmacovigilance & Safety
CategoryPharmacovigilance Solution
Description

Pharmacovigilance and safety documentation solution supporting modular authoring for DSURs, PSURs, RMPs, signal evaluation documentation, investigator brochures, and clinical narratives with version control and traceability. For safety writing and pharmacovigilance teams.

7Quality & SOPs
CategoryQuality & SOP Management Solution
Description

Quality documentation and SOP management solution replacing static SOPs with structured, version-controlled content components governed by built-in audit trails and change management workflows. For quality teams managing SOPs, work instructions, and training documents under GxP compliance.

8Multi Use Case Structured Content
CategoryEnterprise Multi-Function Solution
Description

Cross-functional solution enabling modular content reuse across Regulatory, Medical, Clinical, and CMC use cases with shared structured repository, upstream system integration, and unified governance applied across all functions.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

ArisGlobal's LifeSphere RIM, LifeSphere Quality, and LifeSphere Safety products are direct competitors in pharma regulatory information management and structured content for labeling, submissions, and safety reporting.

TypeDirect peer
Description

LORENZ Life Sciences provides regulatory content management and e-submission software for pharma (docuBridge, LORENZ eCTD), competing with Docuvera in structured authoring and submission publishing workflows.

TypeBroad incumbent
Description

IQVIA's regulatory technology and safety offerings (formerly part of Q² Solutions and broader IQVIA Tech) provide broader, incumbent-scale alternatives to Docuvera's regulatory content and submission solutions.

TypeDirect peer
Description

Sparta's TrackWise quality management platform competes with Docuvera's Quality & SOPs and governance modules for GxP-compliant quality documentation in pharmaceutical manufacturing and operations.

TypeDirect peer
Description

Veeva's Vault RIM, Vault QualityDocs, and Vault Safety suites compete most directly with Docuvera's regulated content authoring platform, targeting the same pharmaceutical regulatory, quality, and safety functions with a broader enterprise cloud platform.

TypeDirect peer
Description

MasterControl's Quality Management System and document/SOP management platform directly competes with Docuvera's Quality & SOPs module in GxP-regulated life sciences quality documentation.

TypeDirect peer
Description

EXTEDO specializes in structured content authoring and regulatory submission management (eCTD, RIM) for life sciences, overlapping directly with Docuvera's global labeling, CMC, and submission-ready content modules.

TypeDirect peer
Description

Acolad/Amplexor's life sciences content management and regulatory submission solutions compete with Docuvera in pharma documentation, multilingual content, and submission publishing.

TypeDirect peer
Description

DXC's life sciences regulatory solutions, inherited from CSC, include regulatory information management and submission services that overlap with Docuvera's structured content and submission publishing offerings.

10Oracle Health Sciences
TypeBroad incumbent
Description

Oracle's Clinical One, Argus Safety, and Health Sciences Data Management offerings are broader enterprise alternatives in pharma regulatory and clinical operations where Docuvera competes.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration15 records

Each record includes

Title, Type, Description, Source

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Docuvera

Pharmaceutical Regulatory Content Management Softwaredocuvera.com

Docuvera is a private Seattle-based SaaS company that provides an AI-powered, component-based structured content authoring platform for regulated life sciences documentation, serving enterprise and mid-sized pharmaceutical companies with modules covering labeling, clinical, CMC, medical information, pharmacovigilance, quality, and governance workflows.

What Docuvera does

Docuvera, operating as Docuvera Software Corporation, is a private Seattle-based software company that provides an AI-powered structured content authoring platform purpose-built for regulated life sciences documentation. The company serves enterprise and mid-sized pharmaceutical organizations globally, with offices in Seattle (North America), Wellington and Palmerston North (APAC), and Gütersloh (Europe), and a stated customer footprint across the U.S., EU, APAC, and LATAM. Named reference customers include Eli Lilly and Boehringer Ingelheim.

The platform is built on a modular, component-based content architecture with metadata tagging, component-level version control, audit history, and a governance layer providing role-based access control, GxP-aligned workflow orchestration, and change propagation across linked documents. It is delivered as validated SaaS hosted on SOC 2 Type 2 and ISO 27001 certified infrastructure, with alignment to 21 CFR Part 11 and EU Annex 11. The product portfolio spans a core platform and seven specialized modules covering Global Labeling, Clinical, Chemistry Manufacturing & Controls, Medical Information, Pharmacovigilance & Safety, Quality & SOPs, and a Governance Layer, supplemented by an AI Co-writer that uses retrieval-augmented generation with human-in-the-loop controls. The platform integrates with LIMS, MES, safety and clinical systems, RIM, translation management systems, and standards including HL7 FHIR, CDISC, USDM, ISO IDMP, and TransCelerate DDF, and publishes outputs in eCTD, PDF, XML, SPL, ePI, Word, and HTML formats. Documented customer outcomes include up to 80% content reuse across labeling outputs, 65% component reuse at Eli Lilly in the first year, 30–50% reduction in change implementation cycle time, 30–40% reduction in review cycle times, and 60% fewer downstream publishing errors.

Docuvera monetizes via a recurring SaaS subscription model, sold through direct enterprise sales engagement, demo requests, and website contact forms. Pricing is not publicly disclosed and is negotiated on a quote basis. The company employs 51–100 people and is privately held with no disclosed parent company, venture capital funding, or ownership changes identified. Distribution is direct, with no disclosed reseller or marketplace channels, and go-to-market is reinforced by content marketing, industry conference participation, and thought-leadership assets aimed at regulatory, clinical, and labeling functions within pharmaceutical companies.

Docuvera firmographics

Firmographics
Name
Docuvera
Legal name
Docuvera Software Corporation
Website
https://docuvera.com
Company type
Private
Operating status
Operating
Headcount range
51–100 employees
Short description
Docuvera is a private Seattle-based SaaS company that provides an AI-powered, component-based structured content authoring platform for regulated life sciences documentation, serving enterprise and mid-sized pharmaceutical companies with modules covering labeling, clinical, CMC, medical information, pharmacovigilance, quality, and governance workflows.
Ownership category
akta.pro rank

Docuvera industry classification

Industry
Product category
Pharmaceutical Regulatory Content Management Software
NAICS
Software Publishers (5132)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACAOAA
Electronic Data Capture (EDC) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)

Keywords

  • Structured content authoring
  • Pharmaceutical documentation
  • Regulatory content management
  • Life sciences compliance software
  • Pharma labeling platform

Where Docuvera is headquartered

Location

Headquarters

HQ city
Wellington
HQ country
New Zealand
HQ region
Oceania

Offices4 records

Markets served

Docuvera business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. SaaS Subscription Platform: Docuvera operates as a validated SaaS solution providing access to their structured content authoring platform on a subscription basis. The platform is hosted on SOC 2 Type 2 certified infrastructure, indicating a cloud-hosted delivery model with recurring subscription fees.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Docuvera product offering

Product offering

Core offering

Docuvera is an AI-powered structured content authoring SaaS platform purpose-built for regulated life sciences documentation. The platform replaces document-first workflows with modular, version-controlled content components that can be authored once and reused across teams, document types, and global markets, supporting use cases spanning global labeling, clinical, CMC, medical information, pharmacovigilance, and quality/SOP documentation. It is hosted on SOC 2 Type 2 certified infrastructure and certified to ISO 27001, with built-in support for 21 CFR Part 11 and Annex 11 compliance.

Product overview

Docuvera is a unified AI-powered structured content authoring platform purpose-built for regulated life sciences content, comprising a core platform with integrated modules for specific use cases. The platform architecture centers on the Docuvera Platform as the foundation, which enables modular, version-controlled content components that can be authored once and reused across multiple outputs. The solution portfolio includes specialized modules: Global Labeling for CCDS, SmPC, USPI, and ePI management; Clinical for trial documentation; Chemistry, Manufacturing & Controls (CMC) for Module 3 content; Medical Information for scientific response management; Pharmacovigilance & Safety for safety reporting; and Quality & SOPs for quality documentation. A Governance Layer provides enterprise-wide controls including component-level version control, RBAC, and change propagation. The AI Co-writer feature enhances the platform with generative AI capabilities for accelerated drafting and reuse recommendations. All modules share the same underlying platform, content repository, and governance framework, enabling true cross-functional reuse—content created in one module can be surfaced and reused in others.

Differentiator

Problem solved

Functional benefit

Brands

  • Cormeo: A sub-brand or platform mentioned on the company's About page, operating under Docuvera's umbrella.

Products and services

  • Docuvera Platform AI-powered structured content authoring platform purpose-built for regulated life sciences content. Replaces scattered files with modular, traceable, and compliant content components that can be created once and reused across teams, document types, and global markets. For pharmaceutical and life sciences regulatory, clinical, CMC, medical information, safety, and quality teams.
  • Global Labeling Structured content solution for global pharmaceutical labeling including CCDS, SmPC, USPI, and ePI, with support for local and global needs, variant control, and multiformat publishing. For global and local regulatory labeling teams in pharmaceutical companies.
  • Clinical Clinical trial documentation solution enabling standardization of protocols, CSRs, and investigator brochures to streamline workflows, reduce rework, and enable modular collaboration across clinical teams. For clinical operations, medical writing, and regulatory teams.
  • Chemistry, Manufacturing, & Controls (CMC) CMC documentation solution enabling modular authoring and content reuse for Module 3 and site-specific variations, with support for upstream data integration from LIMS, MES, and manufacturing systems. For CMC and regulatory teams managing Module 3 content, product specifications, and variation submissions.
  • Medical Information Medical information solution for managing modular scientific response content with traceability across formats, regions, and delivery channels including digital endpoints, AEM-powered websites, chatbots, and field medical tools. For medical information and medical affairs teams.
  • Pharmacovigilance & Safety Pharmacovigilance and safety documentation solution supporting modular authoring for DSURs, PSURs, RMPs, signal evaluation documentation, investigator brochures, and clinical narratives with version control and traceability. For safety writing and pharmacovigilance teams.
  • Quality & SOPs Quality documentation and SOP management solution replacing static SOPs with structured, version-controlled content components governed by built-in audit trails and change management workflows. For quality teams managing SOPs, work instructions, and training documents under GxP compliance.
  • Multi Use Case Structured Content Cross-functional solution enabling modular content reuse across Regulatory, Medical, Clinical, and CMC use cases with shared structured repository, upstream system integration, and unified governance applied across all functions.

Quantifiable outcome

  • Up to 80% content reuse across CCDS, SmPC, USPI, and ePI outputs
  • +7 more outcomes

Companies that use Docuvera

Customer profile

Named customers2 records

Segments6 records

Ideal customer profiles2 records

Docuvera technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration15 records

AI capability6 records

Feature6 records

Docuvera partnerships and signals

Strategic signal

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Docuvera competitors and assessment

Company assessment

Direct peers

  • ArisGlobal: ArisGlobal's LifeSphere RIM, LifeSphere Quality, and LifeSphere Safety products are direct competitors in pharma regulatory information management and structured content for labeling, submissions, and safety reporting.
  • LORENZ Life Sciences: LORENZ Life Sciences provides regulatory content management and e-submission software for pharma (docuBridge, LORENZ eCTD), competing with Docuvera in structured authoring and submission publishing workflows.
  • Sparta Systems (a Honeywell company): Sparta's TrackWise quality management platform competes with Docuvera's Quality & SOPs and governance modules for GxP-compliant quality documentation in pharmaceutical manufacturing and operations.
  • Veeva Systems: Veeva's Vault RIM, Vault QualityDocs, and Vault Safety suites compete most directly with Docuvera's regulated content authoring platform, targeting the same pharmaceutical regulatory, quality, and safety functions with a broader enterprise cloud platform.
  • MasterControl: MasterControl's Quality Management System and document/SOP management platform directly competes with Docuvera's Quality & SOPs module in GxP-regulated life sciences quality documentation.
  • EXTEDO: EXTEDO specializes in structured content authoring and regulatory submission management (eCTD, RIM) for life sciences, overlapping directly with Docuvera's global labeling, CMC, and submission-ready content modules.
  • Acolad (formerly Amplexor Life Sciences): Acolad/Amplexor's life sciences content management and regulatory submission solutions compete with Docuvera in pharma documentation, multilingual content, and submission publishing.
  • DXC Technology (formerly CSC Life Sciences): DXC's life sciences regulatory solutions, inherited from CSC, include regulatory information management and submission services that overlap with Docuvera's structured content and submission publishing offerings.

Broad incumbents

  • IQVIA: IQVIA's regulatory technology and safety offerings (formerly part of Q² Solutions and broader IQVIA Tech) provide broader, incumbent-scale alternatives to Docuvera's regulatory content and submission solutions.
  • Oracle Health Sciences: Oracle's Clinical One, Argus Safety, and Health Sciences Data Management offerings are broader enterprise alternatives in pharma regulatory and clinical operations where Docuvera competes.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Docuvera social profiles

Digital presence

Docuvera compliance and trust

Trust signal

Compliance4 records

Docuvera financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Docuvera leadership team

Management profile

Number of profiles

Docuvera subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Docuvera funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Docuvera M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Docuvera

What does Docuvera do?

Docuvera is an AI-powered structured content authoring SaaS platform purpose-built for regulated life sciences documentation. The platform replaces document-first workflows with modular, version-controlled content components that can be authored once and reused across teams, document types, and global markets, supporting use cases spanning global labeling, clinical, CMC, medical information, pharmacovigilance, and quality/SOP documentation. It is hosted on SOC 2 Type 2 certified infrastructure and certified to ISO 27001, with built-in support for 21 CFR Part 11 and Annex 11 compliance.

Is Docuvera a public or private company?

Docuvera is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Docuvera founded?

Docuvera was founded in -1. It employs 51 to 100 people.

Where is Docuvera based?

Docuvera is headquartered in Wellington, New Zealand, in the Oceania region.

How does Docuvera make money?

One revenue line is on record: saaS Subscription Platform.

Who are Docuvera's main competitors?

Direct peers on record are ArisGlobal, LORENZ Life Sciences, Sparta Systems (a Honeywell company), Veeva Systems, MasterControl, EXTEDO, Acolad (formerly Amplexor Life Sciences) and DXC Technology (formerly CSC Life Sciences). Broad incumbents are IQVIA and Oracle Health Sciences.

Does Docuvera have an API?

No public API is recorded for Docuvera.

What industry is Docuvera in?

Docuvera's product category is Pharmaceutical Regulatory Content Management Software. Its primary akta.pro industry code is HLACAOAA, Electronic Data Capture (EDC) Platforms. Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals